Dr. Rohit Thummalapalli

Dr. Rohit Thummalapalli, MD, is a board-certified medical oncologist specializing in the treatment of gastrointestinal cancers. He combines a strong foundation in cancer biology and genetics with clinical expertise to deliver evidence-based, individualized care for patients with neuroendocrine tumors, bile duct cancers, and a broad range of other gastrointestinal malignancies. His medical training encompassed both laboratory-based and clinical research, an experience that continues to inform how he approaches each patient's care, tailoring treatment plans to the molecular biology of their disease.

As a clinical investigator, Dr. Thummalapalli leads research efforts focused on developing new therapies for gastrointestinal cancers, with a particular emphasis on neuroendocrine tumors and cholangiocarcinoma. He directs clinical trials exploring novel targeted therapies and immunotherapies, working to translate advances in cancer biology into meaningful treatment options for patients. His dual expertise in bench and clinical research positions him to identify opportunities where emerging science can directly benefit those in his care.

Dr. Thummalapalli places a strong emphasis on the patient-physician relationship, viewing cancer care as a collaborative and deeply personal journey. He works closely with multidisciplinary teams of surgeons, radiation oncologists, interventional radiologists, and nuclear medicine specialists to provide comprehensive, personalized care at every stage of diagnosis and treatment. He approaches each clinical encounter with the goal of making treatment decisions together with his patients, accompanying them through what is often one of the most challenging periods of their lives.